Medicrea (EPA:ALMED) said today it filed a 510(k) submission to the FDA seeking approval of its 3D-printed titanium interbody devices. The New York City and Lyon, France-based company’s 3D-printed interbody device services include compatible UNiD Lab personalized surgical planning and analytical services, the company said. “As the 1st company in spine to develop the highly technical capabilities […]
Medicrea (EPA:ALMED) said it raised a funding round worth about $22.3 million for its UniD patient-specific spinal rod technology and tapped GMEd co-founder Richard Kienzle as its new chief commercial & business development officer. New York City and Lyon, France-based Medicrea said the €20 million round consisted of about $16.8 million (€15 million) in 4-year, 6.75% […]
Medicrea said it won 510(k) clearance from the FDA for its UNiD device, billed as the world’s 1st patient-specific spinal osteosynthesis rod.
MASSDEVICE ON CALL — A team of French doctors were the 1st to implant a patient with a customized spinal cage, thanks to 3D printed technology and development by device maker Medicrea.
Medicrea’s UNiD system 1st creates 3D digital images of a patient’s spinal anatomy, using them as a blueprint to produce an inter-body device aligned perfectly to the patients’ spine. The cages separate the vertebrae to restore proper alignment, with a spinal screw for added stability.